ZRANB3 in African Populations: New Type 2 Diabetes risk locus identified

Last Updated on

August 03, 2019 – Africa is considered the original cradle of all humanity, to which all humans can trace their genetic origin. This may be very interesting in the context of diseases that are due to genetic predispositions both in todays African populations and in all the populations descendant of African origin worldwide.

In a very remarkable study along these lines, a research team led by investigators at the National Institutes of Health genotyped, as part of the Africa America Diabetes Mellitus (AADM) Study, some 18 million autosomal SNPs in 2,343 participants from Nigeria, Ghana, or Kenya with type 2 diabetes (T2D) and 2,889 unaffected controls from the same populations who had similar average body mass indexes. The team reported online in Nature Communications that it started previously with a genome-wide association study that included more than 5200 individuals from Nigeria, Ghana, and Kenya with or without T2D. There, they identified 32 loci linked to T2D in prior studies, which were mainly conducted in individuals of European descent, as well as a new association involving a locus near ZRANB3, that belongs to the SNF2 family of DNA-dependent ATPases that function in replication stress response and catalyze remodeling of stalled replication forks. Along with the already known T2D risk loci, the analyses highlighted two ZRANB3 SNPs, which were missing from the 1000 Genomes Project (1KGP) database and the Genome Aggregation Database (GnomAD) and are suspected of being specific to some African populations. In a validation analysis that included T2D cases and controls from a Zulu population in South Africa, which had lower population frequencies of both SNPs compared to the AADM cohort, the team noted consistent directional effects, though the ties to T2D appeared to be less pronounced.

The findings of this study further demonstrate why it is important to study all human populations. By doing so, novel discoveries that will not only help the specific population but also people all around the globe are going to be made. Moreover, in the early days of large-scale genomic studies, the effect of genes found through statistical tests were not known. Today, with the availability of new genomic tools, a logical step in the present case is to ask: What does ZRANB3 do? How does it confer risk for T2D, and by what mechanisms does it act? Are these mechanisms unique to individuals of African population descent only? What is (are) the resulting clinical phenotype(s)? Overall, this kind of studies only will eventually provide the knowledge that will help the results become actionable for patients in theragenomic medicine.

Thus, for those functional experiments, the team used RNA sequencing, CRISPR-Cas9-based gene knockouts, and other approaches for fiddling with the expression of ZRANB3 in a zebrafish pancreas model of T2D. Results from such experiments indicated that the number of insulin-producing beta cells in the pancreas decrease as ZRANB3 activity is dialed down, results confirmed with small interfering RNA-based gene knockdown experiments in mice. If confirmed in humans, these results may indicate the in the ZRANB3 affected African populations, regulation of insulin-producing beta cells may be one of the mechanisms behind T2D, and that, consequently, this regulation could become a target for therapeutic intervention.

When they looked for T2D associations with more than 100 SNPs implicated in the condition in the past, the researchers verified 32 of these risk loci in the Nigerian, Ghanaian, or Kenyan cases, among them TCF7L2rs7903146, MCM6, DARS, DGKB, GTF3AP5-AGMO, IL23R/IL12RB2, SLC44A4. A handful more risk loci came out of the GWAS meta-analysis, which included data for almost 8,600 participants from African, African American, and other populations.

Print Friendly, PDF & Email

 

Tags: , , , , , , , ,
About the Author
thassodotcom Ph.D.; Professor in Pharmacology and Toxicology. Senior expert in theragenomic and personalized medicine and individualized drug safety. Senior expert in pharmaco- and toxicogenetics. Senior expert in human safety of drugs, chemicals, environmental pollutants, and dietary ingredients.

Leave a Reply

Optional: Social Subscribe/Login




avatar
  Subscribe  
Notify of

thasso: conditions

thasso: tweets

thasso post: magazine

View my Flipboard Magazine.

thasso: categories

thasso: archives

thasso: simple chat

You must be a registered user to participate in this chat.

  • Researchers identify new gene mutation in familial thyroid cancers November 20, 2019
    Researchers from Penn State College of Medicine identified a new gene mutation that may cause a type of familial thyroid cancer. Dr. Darrin Bann, an otolaryngology resident at the College of Medicine and lead author of the study, said that this mutation is the first and only mutation associated with familial thyroid cancer to be […]
  • Researchers develop new database of druggable fusion targets November 20, 2019
    When sections from two separate genes merge due to various factors, such as translocation or splicing, the hybrid that is formed is called a gene fusion. In recent years, it has been discovered that these fusion events play a vital role in the development of cancers and other complex diseases. However, there are very few […]
  • Early results of CRISPR gene-editing treatment shows promise in first human trials November 20, 2019
    Officials from Vertex Pharmaceuticals and CRISPR Therapeutics have announced that preliminary results from testing CRISPR gene-editing treatment in human patients with blood disorders show promise thus far. The joint project between the two firms is taking place at one location in Europe and another in the United States. The results have been posted on the […]
  • Whole-genome sequencing analysis to find more exact biomarkers November 20, 2019
    A new study from Uppsala University shows that whole-genome sequencing increases the precision of genetic studies, which in turn can improve our understanding of how to use biomarkers to discover disease. The results are published in the scientific journal Scientific Reports.
  • Complex organ models grown in the lab November 19, 2019
    Scientists at the University of Würzburg have successfully produced human tissues from stem cells. They have a complexity similar to that of normal tissue and are far superior to previous structures.
  • Outback telescope captures Milky Way center, discovers remnants of dead stars November 20, 2019
    A radio telescope in the Western Australian outback has captured a spectacular new view of the centre of the galaxy in which we live, the Milky Way.The image from the Murchison Widefield Array (MWA) telescope shows what our galaxy would look like if human eyes could see radio waves.
  • Leadership's in the blood for tiny fish November 20, 2019
    Leadership during cooperation runs in the family for tiny fish called Trinidadian guppies, new research shows.
  • Non-invasive microscopy detects activation state and distinguishes between cell types November 20, 2019
    Most analytical methods in biology require invasive procedures to analyze samples, which leads to irreversible changes or even their destruction. Here, researchers from Osaka University develop a non-invasive, label-free optical approach along with statistical tools to reveal immune cell type, cell activation state, and single cell heterogeneity.
  • Living in ethnic enclaves may improve pregnancy outcomes for Asian/Pacific islanders November 20, 2019
    Among Asian/Pacific Islander women living in the United States, those who reside in ethnic enclaves--areas with a high concentration of residents of a similar ancestry--are less likely to have pregnancy or birth complications than those living in other areas, suggests a study by researchers at the National Institutes of Health and other institutions.
  • Study: Young children can learn math skills from intelligent virtual characters November 20, 2019
    A new study examined whether young children's verbal engagement with an onscreen interactive media character could boost their math skills. The study concluded that children's parasocial (that is, one-sided) emotional relationships with the intelligent character and their parasocial interactions (in this case, talking about math with the character) led to quicker, more accurate math responses […]
Top